PL3231417T3 - Odporna na składowanie kompozycja oftalmiczna - Google Patents
Odporna na składowanie kompozycja oftalmicznaInfo
- Publication number
- PL3231417T3 PL3231417T3 PL16165546T PL16165546T PL3231417T3 PL 3231417 T3 PL3231417 T3 PL 3231417T3 PL 16165546 T PL16165546 T PL 16165546T PL 16165546 T PL16165546 T PL 16165546T PL 3231417 T3 PL3231417 T3 PL 3231417T3
- Authority
- PL
- Poland
- Prior art keywords
- storage stable
- ophthalmic compound
- ophthalmic
- compound
- stable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16165546.9A EP3231417B1 (de) | 2016-04-15 | 2016-04-15 | Lagerungsstabile, ophthalmische zusammensetzung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3231417T3 true PL3231417T3 (pl) | 2019-05-31 |
Family
ID=55759507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16165546T PL3231417T3 (pl) | 2016-04-15 | 2016-04-15 | Odporna na składowanie kompozycja oftalmiczna |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11413304B2 (pl) |
| EP (1) | EP3231417B1 (pl) |
| JP (1) | JP7240175B2 (pl) |
| CN (1) | CN109069415B (pl) |
| CA (1) | CA3018636C (pl) |
| ES (1) | ES2704918T3 (pl) |
| MX (1) | MX2018012192A (pl) |
| PL (1) | PL3231417T3 (pl) |
| WO (1) | WO2017178544A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11510924B2 (en) | 2017-05-09 | 2022-11-29 | CARDIX Therapeutics, LLC | Deuterated pharmaceutical compositions and methods of treating cardiovascular diseases |
| JOP20190219A1 (ar) | 2017-05-09 | 2019-09-22 | Cardix Therapeutics LLC | تركيبات صيدلانية وطرق لعلاج أمراض القلب والأوعية الدموية |
| KR20200029374A (ko) * | 2018-09-10 | 2020-03-18 | 삼성바이오에피스 주식회사 | 단백질을 포함하는 액상 조성물 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19511322C2 (de) * | 1995-03-28 | 1999-09-02 | Mann Gerhard Chem Pharm Fab | Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung |
| US5814660A (en) * | 1995-12-22 | 1998-09-29 | Alcon Laboratories, Inc. | 9-oxa prostaglandin analogs as ocular hypotensives |
| JP5301069B2 (ja) | 2004-04-15 | 2013-09-25 | ロート製薬株式会社 | アズレン含有水性液剤 |
| WO2005110439A2 (en) * | 2004-05-07 | 2005-11-24 | S.K. Pharmaceuticals, Inc. | Stabilized hyaluronan preparations and related methods |
| DE102005035986B4 (de) | 2005-07-28 | 2009-10-15 | Bausch & Lomb Incorporated | Steriles tropfbares mehrphasiges emulgatorfreies ophthalmisches Präparat |
| DE102006049091A1 (de) | 2006-10-18 | 2008-04-24 | Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh | Emulgatorfreies ophthalmisches Präparat enthaltend Pflanzenöl |
| JP5083502B2 (ja) | 2006-12-25 | 2012-11-28 | ライオン株式会社 | 眼科用組成物 |
| DE102009009758A1 (de) * | 2009-02-20 | 2010-08-26 | Beiersdorf Ag | Hautpflege-Formulierungen mit einem sofort spürbaren Straffungseffekt |
| US9278132B2 (en) | 2012-02-13 | 2016-03-08 | Bausch & Lomb Incorporated | Ophthalmic pharmaceutical compositions and methods of making and using same |
| EP2630952A1 (en) * | 2012-02-23 | 2013-08-28 | Novagali Pharma S.A. | Self-preserved oil dispersions comprising boric acid |
| DE102012221224A1 (de) * | 2012-11-20 | 2014-05-22 | Beiersdorf Ag | Hydrodispersion mit verbesserter Leistung |
| JP2014148450A (ja) | 2013-02-01 | 2014-08-21 | Hitachi Chemical Co Ltd | ルチル型酸化チタンナノロッドの製造方法及びルチル型酸化チタンナノロッド |
| US9907750B2 (en) | 2013-03-19 | 2018-03-06 | Senju Pharmaceutical Co., Ltd. | Two-layer separation-type eye drop containing squalane |
| DE102014202377A1 (de) * | 2014-02-10 | 2015-08-13 | Beiersdorf Ag | Stabile kosmetische Hydrodispersion |
| CN104306430B (zh) | 2014-10-29 | 2015-10-28 | 东莞市达庆医疗器械有限公司 | 一种医用生物眼部冷疗敷料及其制备方法 |
-
2016
- 2016-04-15 EP EP16165546.9A patent/EP3231417B1/de active Active
- 2016-04-15 ES ES16165546T patent/ES2704918T3/es active Active
- 2016-04-15 PL PL16165546T patent/PL3231417T3/pl unknown
-
2017
- 2017-04-12 US US16/089,715 patent/US11413304B2/en active Active
- 2017-04-12 CN CN201780023702.3A patent/CN109069415B/zh active Active
- 2017-04-12 MX MX2018012192A patent/MX2018012192A/es active IP Right Grant
- 2017-04-12 WO PCT/EP2017/058825 patent/WO2017178544A1/de active Application Filing
- 2017-04-12 JP JP2018549558A patent/JP7240175B2/ja active Active
- 2017-04-12 CA CA3018636A patent/CA3018636C/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US11413304B2 (en) | 2022-08-16 |
| JP2019515882A (ja) | 2019-06-13 |
| CN109069415A (zh) | 2018-12-21 |
| CN109069415B (zh) | 2022-04-29 |
| MX2018012192A (es) | 2019-02-11 |
| CA3018636A1 (en) | 2017-10-19 |
| US20190111075A1 (en) | 2019-04-18 |
| EP3231417A1 (de) | 2017-10-18 |
| JP7240175B2 (ja) | 2023-03-15 |
| CA3018636C (en) | 2021-05-11 |
| WO2017178544A1 (de) | 2017-10-19 |
| ES2704918T3 (es) | 2019-03-20 |
| EP3231417B1 (de) | 2018-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3389130A4 (en) | Lead storage battery | |
| EP3389131A4 (en) | Lead storage battery | |
| EP3366930A4 (en) | ACCUMULATOR | |
| EP3291154A4 (en) | Storage cabinet | |
| EP3291153A4 (en) | Storage cabinet | |
| KR101882077B1 (ko) | 소품류의 수납 케이스 | |
| IL262789B (en) | Herbicidal preparations containing glufosinate are stable | |
| EP3312434A4 (en) | Accumulator | |
| EP3352285A4 (en) | Lead storage battery | |
| EP3040290A4 (en) | Scented-tissue-paper storage body | |
| AU201617038S (en) | Storage case | |
| EP3402714A4 (en) | STORAGE DEVICES | |
| EP3386912A4 (en) | HYDROGEN STORAGE ASSEMBLY | |
| EP3290361A4 (en) | Storage cabinet | |
| EP3279481A4 (en) | Accumulator | |
| PL3231417T3 (pl) | Odporna na składowanie kompozycja oftalmiczna | |
| EP3436923C0 (en) | STORAGE CLUSTER | |
| EP3394787A4 (en) | ENHANCED MEMORIZATION SYSTEM | |
| EP3404271A4 (en) | ACCUMULATOR | |
| EP3349873A4 (en) | CARTRIDGE BATTERY | |
| EP3534092A4 (en) | ACCUMULATOR | |
| EP3162800A4 (en) | Fungicidal agent | |
| GB2547330B (en) | Storage arrangement for well operations | |
| EP3550156A4 (en) | ACCUMULATOR | |
| EP3418584A4 (en) | ACCUMULATOR |